celiprolol has been researched along with hypoxanthine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, J; Endo, S; Hamada, T; Hasegawa, A; Hisatome, I; Kato, M; Mishima, M; Miyazaki, S; Mizuta, E; Ninomiya, H; Ogino, K; Ohtahara, A; Taniguchi, SI; Utami, SB; Yamada, K; Yamamoto, K | 1 |
1 trial(s) available for celiprolol and hypoxanthine
Article | Year |
---|---|
A vasodilating β1 blocker celiprolol inhibits muscular release of uric acid precursor in patients with essential hypertension.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Blood Pressure; Celiprolol; Exercise Test; Female; Forearm; Heart Rate; Humans; Hypertension; Hypoxanthine; Ischemia; Male; Middle Aged; Muscles; Uric Acid; Vasodilator Agents | 2013 |